Funding from the NSERC (Natural Sciences and Engineering
Research Council of Canada) Engage program is gratefully
acknowledged. The Faculty of Medicine and Health Sciences of
Université de Sherbrooke is acknowledged for summer internship
to C. St-Georges and M.-A. Legault.
Experimental
Representative procedure: synthesis of amide 25
To 500 mg (1.5 mmol) of DPA ethyl ester as an oil were
added 100 mg of Novozym 435© lipase on resin and 5 eq (7.5
mmol) of serinol. A minimum amount of acetone was then added
to decrease viscosity (1 mL). The mixture was magnetically
stirred for 4-18 h at 35°C until TLC indicated complete
disappearance of the ethyl ester (to be noted, LC-MS methods
with UV detection are not useful to follow these reactions owing
to the very low absorbance of the chromophores). The reaction
was then filtered, acetone was evaporated then water added. The
mixture was extracted with a minimal amount of diethyl ether (1
mL) thrice. The organic phase was dried with magnesium
sulphate, filtered then evaporated under reduced pressure. The
crude product was purified by flash chromatography with
hexane/ethyl acetate to give the desired amide 25 as a colorless
oil in 60% yield (> 90% purity by1H NMR).
References and notes
1.
2.
3.
Feltes, M. M. C.; Oliveira, D; Block, J. M.; Ninow, J. L.;
2013, , 17.
Morin, C.; Fortin, S.; Cantin, A. M.; Rousseau, E.;
2013, , 1071.
Cruz-Hernandez, C.; Thakkar, S. K.; Moulin, J.; Oliveira,
M.; Masserey-Elmelegy, I.; Dionisi, F.; Destaillats, F.; B
2012, , 1781.
4.
5.
Morin, C.; Fortin, S.; Cantin, A. M.; Rousseau, E.;
2011, , 36.
Cho, K. L.; Lee, J. H.; Kim, J. M.; Park, S. H.; Choi, M. S.;
Lee, Y. M.; Choi, I.; Lee, K.T.; 2009, ,
452.
1H NMR (300MHz, CDCl3) (ppm): 6.52 (d, 1H, 7.2 Hz), 5.43-
5.29 (m, 10H), 4.98 (s, 2H), 3.94-3.91 (m, 1H), 3.81 (dd, 2H, 3.9
Hz, 4.2 Hz), 3.70 (dd, 2H, 4.8 Hz, and 5.1 Hz), 2.89-2.79 (m,
10H), 2.32 (t, 2H, 8.3 Hz), 2.22 (t, 2H, 7.5 Hz), 2.07 (quint, 2H,
7.1 Hz), 1.63 (quint, 4H, 7.2Hz), 1.42-1.30 (m, 6H), 1.26-1.24
(m, 2H), 0.97 (t, 3H, 7.7 Hz).
6.
7.
Morin, C.; Rousseau, E.; Fortin, S.; .
2013, , 203.
Morin, C.; Fortin, S.; Cantin, A. M.; Sirois, M.; Sirois, C.;
Rizcallah, E.; Rousseau, E.;
2013, , 319.
Chon, S. H.; Zhou, Y. X.; Dixon, J. L.; Storch, J.;
2007, , 33346.
Dang, H. T.; Kang, G. J.; Yoo, E. S.; Hong, J.; Choi, J. S.;
Kim, H. S.; Chung, H. Y.; Jung, J. H.;
2011, , 1520.
single/article/impurities-guideline-for-residual-
solvents.html.
8.
9.
13C NMR (75.5 MHz, CDCl3) (ppm): 178.57, 174.71, 132.02,
130.01, 128.56, 128.41, 128.23, 128.13, 128.01, 127.90, 127.03,
61.93, 52.45, 36.55, 34.19, 29.31, 28.91, 28.80, 27.07, 25.64,
25.53, 24.78, 20.56, 14.29.
10.
IR (CHCl3) (cm-1): 3330, 3011, 2931, 2858, 1709, 1650, 1547,
1461, 1266, 1051, 975, 720.
HRMS (M-H+) C25H42NO3; calc: 404.3159; measured: 404.3164
11.
Prat, D. H.; Hayler, J.; Wells, A.; 2014, DOI:
10.1039/c4gc01149j.
12.
13.
Ast, H., 1963, , 1539.
Boey, P. M.; Maniam, G.P.; Hamid, S.A.;
2011, , 15.
Anitescu, G.; Bruno, T.J.; 2012, ,
133.
Fan, X.; Niehus, X.; Sandoval, G.; 2012,
, 471.
Veras, I. C.; Silva, F. A.; Ferrao-Gonzales, A. D.; Moreau,
V. H.; 2011, , 9653.
Cervero, J. A.; Alvarez, JR; Luque, S,
.2014, , 131.
Poppe, J. K.; Garcia-Galan, J.; Matte, C. R.; Fernandez-
Lafuente, R.; Rodrigues, R. C.; Ayub, M. A. Z.,
. 2013, , 51.
Weiberth, F. Y.; Yu, Y.; Subotkowski, W.; Pemberton, C;
2012, , 1967.
Islam, M. K.; Curie, Y. M. ; Gossage, J.L.; Benson, T.J.;
.2013, , 1564.
Chang, H. M.; Liao, H. F.; Lee, C. C. ; Shieh, C. J.
2005, , 307.
Mergen, F. L.; Lambert, D. M.; Poupaert, J. H. ; Bidaine,
A.; Dumont, P.; .1991, , 267.
Zhang, J. C.; Cai, D.; Tang, W.; Zhang, Z.; Liu, Y.; Gao,
X.; 2014, , 871.
Cell culture
Human A549 lung adenocarcinoma cells were obtained from
the American Type Culture Collection (ATCC). A549 cells were
maintained in RPMI 1640 (Wisent, St-Bruno, QC, Canada)
containing 10 % FBS and 10 units/mL penicillin, 100 µg/mL
streptomycin. Cells were grown in a 5% CO2 incubator at 37°C
and used between passage 3 to 6 for all conditions and assays
tested in this study.
14.
15.
16.
17.
18.
Growth inhibition assay
A predefined number of A549 cells were allowed to grow in
24 wells plates (1 × 104 cells/well) for 3 days until cells reached
60% confluence. They were then starved in RPMI medium
without FBS for 8 h, then the culture medium was replaced with
RPMI + 0.2 % FBS and 3 µM of test compound were added to
each well. Culture media were changed every 24 h and cells were
treated for 48 h. After 48 h, the medium was removed from the
culture plates and 0.05% trypsin EDTA was used to detach the
cells from the surface of the culture plates. The harvested cells
were counted, both the viable and dead ones, using a Countess
Automated Cell Counter (Invitrogen Inc.). Briefly, for each
condition an appropriated cell dilution was prepared from the
harvested cells and an aliquot was mixed with an equal volume
of 0.4% trypan blue, and 10 µL was transferred into each side of
concentrations tested were
19.
20.
21.
22.
23.
performed in triplicata and were representative of 5 independent
experiments.
Acknowledgments